These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Drugs and the renin-angiotensin system in covid-19. Aronson JK, Ferner RE. BMJ; 2020 Apr 02; 369():m1313. PubMed ID: 32241880 [No Abstract] [Full Text] [Related]
4. Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19. Furuhashi M, Moniwa N, Takizawa H, Ura N, Shimamoto K. Hypertens Res; 2020 Aug 02; 43(8):837-840. PubMed ID: 32433641 [No Abstract] [Full Text] [Related]
5. Angiotensin converting enzyme 2 at the interface between renin-angiotensin system inhibition and coronavirus disease 2019. Siri-Angkul N, Chattipakorn SC, Chattipakorn N. J Physiol; 2020 Oct 02; 598(19):4181-4195. PubMed ID: 32710575 [Abstract] [Full Text] [Related]
6. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. N Engl J Med; 2020 Apr 23; 382(17):1653-1659. PubMed ID: 32227760 [No Abstract] [Full Text] [Related]
11. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update. Shukla AK, Banerjee M. High Blood Press Cardiovasc Prev; 2021 Mar 01; 28(2):129-139. PubMed ID: 33635533 [Abstract] [Full Text] [Related]
13. Angiotensin Receptor Blockers Are Not Just for Hypertension Anymore. Saavedra JM. Physiology (Bethesda); 2021 May 01; 36(3):160-173. PubMed ID: 33904788 [Abstract] [Full Text] [Related]
14. The Role of the Renin-Angiotensin System in Severe Acute Respiratory Syndrome-CoV-2 Infection. Alfano G, Guaraldi G, Fontana F, Ferrari A, Magistroni R, Mussini C, Cappelli G, Modena Covid-19 Working Group (MoCo19). Blood Purif; 2021 May 01; 50(2):263-267. PubMed ID: 32344395 [No Abstract] [Full Text] [Related]
16. Potential Roles of the Renin-Angiotensin System in the Pathogenesis and Treatment of COVID-19. Lu L, Liu X, Jin R, Guan R, Lin R, Qu Z. Biomed Res Int; 2020 May 01; 2020():7520746. PubMed ID: 33204713 [Abstract] [Full Text] [Related]
17. Discontinuation of Antihypertensive Medications on the Outcome of Hospitalized Patients With Severe Acute Respiratory Syndrome-Coronavirus 2. Singh S, Offringa-Hup AK, Logtenberg SJJ, Van der Linden PD, Janssen WMT, Klein H, Waanders F, Simsek S, de Jager CPC, Smits P, van der Feltz M, Jan Beumer G, Widrich C, Nap M, Pinto-Sietsma SJ. Hypertension; 2021 Jul 01; 78(1):165-173. PubMed ID: 34106731 [Abstract] [Full Text] [Related]
18. COVID-19 and Liver Cirrhosis: Focus on the Nonclassical Renin-Angiotensin System and Implications for Therapy. Sansoè G, Aragno M, Wong F. Hepatology; 2021 Aug 01; 74(2):1074-1080. PubMed ID: 33524188 [Abstract] [Full Text] [Related]
19. Angiotensin-converting enzyme 2 as a versatile player in the management of coronavirus disease 2019. Amano T. J Diabetes Investig; 2020 Sep 01; 11(5):1120-1122. PubMed ID: 32657484 [No Abstract] [Full Text] [Related]
20. Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study. Conversano A, Melillo F, Napolano A, Fominskiy E, Spessot M, Ciceri F, Agricola E. Hypertension; 2020 Aug 01; 76(2):e10-e12. PubMed ID: 32383626 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]